Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S C Wadsworth

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Human Gene Therapy|October 1, 1995
Characterization of an adenovirus gene transfer vector containing an E4 deletionD Armentano, C C Sookdeo, K M Hehir, et al.
Human Gene Therapy|March 1, 1997
Safety of airway gene transfer with Ad2/CFTR2: aerosol administration in the nonhuman primateR J McDonald, M J Lukason, O G Raabe, et al.
The American Journal of Physiology|October 1, 1996
Ability of adenovirus vectors containing different CFTR transcriptional cassettes to correct ion transport defects in CF cellsC Jiang, S P O'Connor, D Armentano, et al.
Journal of Virology|March 1, 1997
Effect of the E4 region on the persistence of transgene expression from adenovirus vectorsD Armentano, J Zabner, C Sacks, et al.
Gene Therapy|September 7, 1999
The extra- and intracellular barriers to lipid and adenovirus-mediated pulmonary gene transfer in native sheep airway epitheliumC Kitson, B Angel, D Judd, et al.
Human Gene Therapy|April 10, 1997
Increased contact time improves adenovirus-mediated CFTR gene transfer to nasal epithelium of CF miceC Jiang, G Y Akita, W H Colledge, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 18, 2000
Adenoviral vector expressing ICP47 inhibits adenovirus-specific cytotoxic T lymphocytes in nonhuman primatesA Scaria, J A Sullivan, J A St George, et al.
Human Gene Therapy|July 29, 1998
Potentiation of gene transfer to the mouse lung by complexes of adenovirus vector and polycations improves therapeutic potentialJ M Kaplan, S E Pennington, J A St George, et al.
Human Gene Therapy|August 4, 2001
Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. I. Methods, safety, and clinical implicationsP M Joseph, B P O'Sullivan, A Lapey, et al.
Human Gene Therapy|January 1, 1997
Characterization of factors involved in modulating persistence of transgene expression from recombinant adenovirus in the mouse lungJ M Kaplan, D Armentano, T E Sparer, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Human Gene Therapy|October 1, 1995
Characterization of an adenovirus gene transfer vector containing an E4 deletionD Armentano, C C Sookdeo, K M Hehir, et al.
Human Gene Therapy|March 1, 1997
Safety of airway gene transfer with Ad2/CFTR2: aerosol administration in the nonhuman primateR J McDonald, M J Lukason, O G Raabe, et al.
The American Journal of Physiology|October 1, 1996
Ability of adenovirus vectors containing different CFTR transcriptional cassettes to correct ion transport defects in CF cellsC Jiang, S P O'Connor, D Armentano, et al.
Journal of Virology|March 1, 1997
Effect of the E4 region on the persistence of transgene expression from adenovirus vectorsD Armentano, J Zabner, C Sacks, et al.
Gene Therapy|September 7, 1999
The extra- and intracellular barriers to lipid and adenovirus-mediated pulmonary gene transfer in native sheep airway epitheliumC Kitson, B Angel, D Judd, et al.
Human Gene Therapy|April 10, 1997
Increased contact time improves adenovirus-mediated CFTR gene transfer to nasal epithelium of CF miceC Jiang, G Y Akita, W H Colledge, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 18, 2000
Adenoviral vector expressing ICP47 inhibits adenovirus-specific cytotoxic T lymphocytes in nonhuman primatesA Scaria, J A Sullivan, J A St George, et al.
Human Gene Therapy|July 29, 1998
Potentiation of gene transfer to the mouse lung by complexes of adenovirus vector and polycations improves therapeutic potentialJ M Kaplan, S E Pennington, J A St George, et al.
Human Gene Therapy|August 4, 2001
Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. I. Methods, safety, and clinical implicationsP M Joseph, B P O'Sullivan, A Lapey, et al.
Human Gene Therapy|January 1, 1997
Characterization of factors involved in modulating persistence of transgene expression from recombinant adenovirus in the mouse lungJ M Kaplan, D Armentano, T E Sparer, et al.
Pageof 5